Noah Lee, DO
Family Medicine · Oakland Park, FLNPI 1275559106
Payments from drug & device makers
Across 2,667 payments — averaging $483.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$490K
- Gilead$431K
- Janssen Products, LP$89K
- EMD Serono, Inc.$69K
- AbbVie$57K
- Theratechnologies Inc.$38K
- plus $116K from 54 others
What the payments were for
- Consulting fees$37,3563%
- Speaking & faculty fees$954,73182%
- Travel & lodging$111,93310%
- Food & beverage$60,4685%
- Education$440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,290,237 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SerostimSomatropin | 115 | $3,366,220 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 759 | $3,232,262 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 254 | $1,354,219 |
| DescovyEmtricitabine/Tenofov Alafenam | 445 | $1,014,216 |
| RukobiaFostemsavir Tromethamine | 71 | $647,461 |
| Egrifta SvTesamorelin Acetate | 73 | $631,092 |
| TivicayDolutegravir Sodium | 229 | $598,898 |
| DovatoDolutegravir Sodium/Lamivudine | 172 | $515,592 |
| PrezcobixDarunavir/Cobicistat | 158 | $406,923 |
| PifeltroDoravirine | 199 | $399,802 |
| IsentressRaltegravir Potassium | 136 | $278,104 |
| CabenuvaCabotegravir/Rilpivirine | 44 | $251,581 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 48 | $209,782 |
| OzempicSemaglutide | 126 | $178,649 |
| MytesiCrofelemer | 33 | $149,909 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $430,799 | $4,356,5161,230 claims |
| EMD Serono, Inc.Serostim | $69,340 | $3,366,220115 claims |
| Viiv Healthcare CompanyRukobia, Tivicay, Dovato, Cabenuva, Triumeq | $490,183 | $2,218,936570 claims |
| Janssen Products, LPSymtuza | $88,982 | $1,354,219254 claims |
| MerckPifeltro, Isentress, Delstrigo, Isentress Hd, Janumet Xr | $23,183 | $840,041439 claims |
| Theratechnologies Inc.Egrifta Sv | $38,229 | $631,09273 claims |
| Johnson & JohnsonPrezcobix, Xarelto, Complera | $35,507 | $560,699275 claims |
| Novo NordiskOzempic | $2,125 | $178,649126 claims |
| Napo Pharmaceuticals IncMytesi | $32,361 | $149,90933 claims |
| AbbVieCreon | $56,855 | $98,58924 claims |
| AstraZenecaFarxiga | $1,410 | $93,521100 claims |
| PfizerEliquis | $466 | $82,23581 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Oakland Park
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.